The advance of researches on polyphenols as a chemoprophylactic agent for colorectal cancer

doi:10.3877/cma.j.issn.2095-3224.2014.05.03

Abstract

Abstract:

Colorectal cancer is one of the most prevalent cancers in many countries, the prognosis of current treatments is not good.Chemoprevention emerges as the time goes by.Among those chemoprevention, plant chemoprevention has became a hot topic, clue to its low cost and its minor side-effect.We will discuss the progress of plant chemoprevention for colorectal tumor in this paper.

Key words: Colorectal neoplasms, Chemoprevention, Polyphenols

Ming LIU. The advance of researches on polyphenols as a chemoprophylactic agent for colorectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2014, 03(05): 327-330.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2014.05.03

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2014/V03/I05/327

Figures/Tables 4

References 26

[1]	Landete JM.Ellagitannins, ellagic acid and their derived metabolites：a review about source, metabolism, functions and health.Food Res Int, 2011, 44: 1150-1160.
[2]	Larrosa M,Garcia-Conesa MT,Espin JC, et al.Ellagitannins, ellagic acid and vascular health.Mol Aspects Med, 2010, 31: 513-539.
[3]	Malik A,Afaq S,Shahid M, et al.Influence of ellagic acid on prostate cancer cell proliferation：a caspase-dependent pathway.Asian Pac J Trop Med, 2011, 4: 550-555.
[4]	Rosillo MA,Sanchez-Hidalgo M,Cárdeno A, et al.Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease.Biochem Pharmacol, 2011, 82: 737-745.
[5]	Honglian Yu,Lijuan Liu.In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T 24 cells.Food and Chemical Toxicology, 2013, 59: 428-437.
[6]	Mishra S,Vinayak M. Ellagic acid induces novel and atypical PKC isoforms and promotes caspase-3 dependent apoptosis by blocking energy metabolism.Nutr Cancer, 2014, 66(4): 675-681.
[7]	Sujatha Ramasamy,Abdul Wahab.Growth inhibition of human gynecologic and colon cancer cells by phyllanthus watsonii through apoptosis induction.PLoS ONE, 2012, 20: 7(4): 34793.
[8]	Juan A,Giméenez-Bastida,Mar Larrosa.Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts.J Agric Food Chem, 2012, 60: 8866-8876.
[9]	Kishor Butte,Munira Momin.Optimisation and in vivo evaluation of pectin based drug delivery system containing curcumin for colon.Int J Biomater, 2014: 924278.
[10]	Das RK,Kasoju N,Bora U. Encapsulation of curcumin in alginate–chitosan–pluronic composite nanoparticles for delivery to cancer cells.Nanomedicine, 2010, 6: 153-160.
[11]	Irving GR,Karmokar A,Berry DP, et al.Curcumin：the potential for efficacy in gastrointestinal diseases.Best Pract Res Clin Gastroenterol, 2011, 25: 519-534.
[12]	Wilken R,Veena MS,Wang MB, et al.Curcumin：A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.Mol Cancer, 2011, 10: 12.
[13]	Vyas A,Dandawate P,Padhye S, et al.Perspectives on new synthetic curcumin analogs and their potential anticancer properties.Curr Pharm Des, 2013, 19(11): 2047-2069.
[14]	Santos S,Bruno M. Nanoencapsulation of polyphenols for protective effect against colon–rectal cancer.Biotechnology Advances, 2013, 31: 514-523.
[15]	Link Alexander,Francesc Balaguer.Curcumin modulates DNA methylation in colorectal cancer cells.PLOS ONE, 2013, 8(2): e57709.
[16]	Radhakrishnan VM,Ramalingam R. pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin：involvement of non-receptor type 1 protein tyrosine phosphatase(PTPN1). PLoS One, 2014, 9(1): 85796.
[17]	Mehdi Shakibaei,Constanze Buhrmann.Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high.Density Cultures, 2014, Jan 3；9(1): e85397.
[18]	Volate SR,Muga SJ,Issa AY, et al.Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/＋ mouse model of intestinal cancer.Molecular carcinogenesis, 2009, 48: 920-933.
[19]	Vondina R,Rebecca W. Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells.Anticancer Res, 2013, 33(12): 5325-5333.
[20]	Fang MZ,Wang Y,Ai N, et al.Tea polyphenol(－)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.Cancer research, 2003, 63: 7563-7570.
[21]	Song Yi,Chang Hee.Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression.Oncology Letters, 2013, 6: 1346-1350.
[22]	Stetler-Stevenson WG.Type IV collagenases in tumor invasion and metastasis.Cancer Metastasis Rev, 1990, 9: 289-303.
[23]	Singh BN,Shankar S,Srivastava RK.Green tea catechin, epigallocatechin-3-gallate(EGCG)：mechanisms, perspectives and clinical applications.Biochem Pharmacol, 2011, 82: 1807-1821.
[24]	Wang Jinhua,Ding Weijia.Three new resveratrol derivatives from the mangrove endophytic fungus alternariasp.Mar Drugs, 2014, 12: 2840-2850.
[25]	De Maria,Maria Cartenì.Polydatin, a natural precursor of resveratrol, induces cell cycle arrest and differentiation of human colorectal Caco-2 cell.Journal of Translational Medicine, 2013, 11: 264.
[26]	Min-Yu Chung,Gyu Lim,Won Lee.Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development.World J Gastroenterol, 2013, 19(7): 984-993.

Please choose a citation manager

Content to export